Global Medical Marijuana Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Medical Marijuana Market is presumed to reach the market size of nearly USD 23.4 Billion by 2032 from USD 18.97 Billion in 2023 with a CAGR of 2.36% under the study period 2024-2032.

Medical marijuana denotes the utilization of the cannabis plant or its derivatives to treat symptoms of illness and other conditions. It is often prescribed to alleviate chronic pain, lower nausea, and vomiting concerned with chemotherapy, stimulate appetite in patients with AIDS, and treat spasticity in multiple sclerosis. It contains cannabinoids such as THC and CBD, which interact with the body's endocannabinoid system to provide therapeutic effects. The legalization and regulation of medical marijuana use vary widely across different regions, reflecting differing societal attitudes and governmental policies toward its use.

MARKET DYNAMICS

The rising recognition of the therapeutic benefits of marijuana is a major driving medical marijuana market. Research and clinical studies have demonstrated its efficacy in treating numerous medical conditions, such as epilepsy, chronic pain, and multiple sclerosis, leading to wider acceptance and adoption in the market. The progressive legalization and regulatory approval of medical marijuana in various regions are significantly boosting the market. As more countries and states legalize its use for medical purposes, the market continues to rise. Additionally, the rising awareness among patients & healthcare providers about the potential health benefits of marijuana is driving market growth. Increased education and information dissemination about its therapeutic uses are encouraging more patients to seek marijuana treatments. Furthermore, advancements in cultivation and extraction technologies are improving the quality and consistency of marijuana products, enhancing their appeal and reliability. These innovations are enabling the production of standardized and high-potency marijuana products, meeting the stringent requirements of the medical community. Moreover, pharmaceutical companies' increasing investment and involvement in the medical marijuana sector contribute to market growth by supporting research, product development, and distribution channels. However, regulatory hurdles and legal complexities may hinder market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Medical Marijuana. The growth and trends of Medical Marijuana industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Medical Marijuana market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Flower
Oil & Tinctures

By Application

Cancer
Chronic Pain
Depression and Anxiety
Arthritis
Diabetes
Glaucoma
Migraines
Epilepsy
Multiple Sclerosis
AIDS
Amyotrophic Lateral Sclerosis
Alzheimer's Disease
Post-Traumatic Stress Disorder (PTSD)
Parkinson's Disease
Tourettes
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Medical Marijuana market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Medical Marijuana market include Tilray, Aurora Cannabis, Canopy Growth Corporation, Aphria Inc., Maricann Group Inc., Tikun Olam Ltd., MedReleaf. Corp., GW Pharmaceuticals Plc., Cannabis Sativa Inc., Medical Marijuana Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11215864

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MEDICAL MARIJUANA - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MEDICAL MARIJUANA MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Flower Historic and Forecast Sales By Regions
5.4. Oil & Tinctures Historic and Forecast Sales By Regions

6. GLOBAL MEDICAL MARIJUANA MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Cancer Historic and Forecast Sales By Regions
6.4. Chronic Pain Historic and Forecast Sales By Regions
6.5. Depression and Anxiety Historic and Forecast Sales By Regions
6.6. Arthritis Historic and Forecast Sales By Regions
6.7. Diabetes Historic and Forecast Sales By Regions
6.8. Glaucoma Historic and Forecast Sales By Regions
6.9. Migraines Historic and Forecast Sales By Regions
6.10. Epilepsy Historic and Forecast Sales By Regions
6.11. Multiple Sclerosis Historic and Forecast Sales By Regions
6.12. AIDS Historic and Forecast Sales By Regions
6.13. Amyotrophic Lateral Sclerosis Historic and Forecast Sales By Regions
6.14. Alzheimer's Disease Historic and Forecast Sales By Regions
6.15. Post-Traumatic Stress Disorder (PTSD) Historic and Forecast Sales By Regions
6.16. Parkinson's Disease Historic and Forecast Sales By Regions
6.17. Tourettes Historic and Forecast Sales By Regions
6.18. Others Historic and Forecast Sales By Regions

7. GLOBAL MEDICAL MARIJUANA MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE MEDICAL MARIJUANA COMPANIES

8.1. Medical Marijuana Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF MEDICAL MARIJUANA INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Tilray
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Aurora Cannabis
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Canopy Growth Corporation
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Aphria Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Maricann Group Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Tikun Olam Ltd.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. MedReleaf. Corp.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. GW Pharmaceuticals Plc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Cannabis Sativa Inc.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Medical Marijuana Inc
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies